Azoles are currently the most widely used class of antifungal drugs clinically, and are effective for treating fungal infections. Target site of azoles is ergosterol biosynthesis in fungal cell membrane, which is absent in the mammalian host. However, the development of resistance to azole treatments in the fungal pathogen has become a significant challenge. Here, we report the identification and functional characterization of a UPC2 homolog in the human pathogen Cryptococcus neoformans. UPC2 plays roles in ergosterol biosynthesis, which is also affected by the availability of iron in Saccharomyces cerevisiae and Candida albicans. C. neoformans mutants lacking UPC2 were constructed, and a number of phenotypic characteristics, including antifungal susceptibility and iron utilization, were analyzed. No differences were found between the mutant phenotypes and wild type, suggesting that the role of C. neoformans UPC2 homolog may be different from those in S. cerevisiae and C. albicans, and that the gene may have a yet unknown function.
Fungal infections have increased dramatically during the last two decades and in most cases, the infections are associated with immunocompromised individuals such as AIDS patients and organ transplant recipients. In order to treat emerging fungal infections, azole (e.g. fluconazole) and polyene (e.g. amphotericin B) antifungal drugs have been developed and widely used. Among them, azoles are the most widely used clinically and are effective against fungal infections. The mode of action of azoles is the disruption of ergosterol synthesis in the fungal cell membrane, which is absent in mammalian and plant counterparts [1] . Azole compounds that have been developed include clotrimazole, miconazole, econazole, isoconazole, ketoconazole and fluconazole. Since their clinical introduction, various azole derivatives have become widely used antifungal drugs due to their safety [2] . Azole derivatives bind to and inhibit Erg11, 14α-methyl sterol demethylase, which cocatalyses cytochrome P-450-dependent 14α-demethylation of lanosterol in ergosterol biosynthetic pathwaysis. ERG3, which encodes ∆ sterol desaturase, is also known to be associated with fluconazole susceptibility of fungi [3] .
The human pathogen Cryptococcus neoformans is a basidiomycetes yeast that causes life-threatening diseases, such as pulmonary cryptococcosis and cryptococcal meningitis, mainly in HIV-positive patients [4] . Indeed, C. neoformans has caused diseases in about 5~10% of all AIDS patients over the past few decades [4] . C. neoformans expresses several virulence factors, such as a polysaccharide capsule and melanin, and its ability to grow at the host body temperature of 37 o C [5] [6] [7] [8] . The capsule is induced by environmental conditions such as iron depletion, CO 2 levels and lack of nutrients. Mutants that lack the ability to synthesize capsule have been reported to be avirulent [6, 7, 9] . Melanin is a polymer of exogenous dihydroxyphenolic compounds that plays a role in virulence by mediating resistance to oxidative stress [10] [11] [12] [13] . The formation of melanin is catalyzed by phenoloxidase laccase, the expression of which is known to be influenced by glucose and also by iron [14] [15] [16] [17] [18] . The calcium/ calcineurin pathway was identified in C. neoformans and was found to contribute to the expression of virulence factors including the ability of the fungus to tolerate the host body temperature [19, 20] .
Due to its clinical significance, much attention has been paid to understand the mechanisms of drug susceptibility and resistance in the fungal pathogens. A number of studies using a model fungus Saccharomyces cerevisiae have revealed regulatory mechanisms of expression of genes involved in ergosterol synthesis. Among them are the S. cerevisiae UPC2 gene and its paralog ECM22, which belong to the fungal Zn(2)-Cyc(6) binuclear cluster family of transcription factors. These transcription factors regulate the expression of ERG2 and ERG3 by binding to sterol response elements in the promoters of these genes [21] . The same protein was identified in Candida albicans. C. albicans UPC2 (CaUPC2) is the homolog of S. cerevisiae UPC2/ECM22, and the mutant lacking CaUPC2 displayed significantly increased sensitivity to the azole antifungals ketoconazole and fluconazole, and overexpression of CaUPC2 increased resistance to these drugs [22] .
*Corresponding author <E-mail : whjung@cau.ac.kr> Genome-wide analysis using a ChIP-chip technique was performed to define downstream target promoters of UPC2 in C. albicans. This study identified 202 promoters including those for ERG11 and the genes encoding drug transporters such as CDR1 and MDR1 [22] . These findings clearly indicated that UPC2 encodes a key regulator that controls the expression of the ERG genes in the ergosterol synthesis pathway and that influences resistance to azole antifungal drugs in some fungi. In this study, we therefore aimed to identify the UPC2/ECM22 homolog in C. neoformans and to characterize its function with regard to drug susceptibility to currently available antifungal drugs including fluconazole. A C. neoformans mutant lacking the UPC2 homolog was constructed by homologous recombination. A number of phenotypic analysis including drug sensitivity and iron utilization were carried out to identify its roles in C. neoformans.
Materials and Methods
Strains and growth conditions. C. neoformans var. grubii H99 (serotype A) was used throughout the study. Strains were maintained in yeast extract and bacto-peptone medium with 2.0% glucose (YPD; Difco, Detroit, MI, USA), or yeast nitrogen base (Difco) with 2.0% glucose. Defined low-iron medium was prepared as described elsewhere [23, 24] . Iron-replete media were prepared by adding FeCl 3 as an iron source. Hemin was added to low-iron media to investigate phenotypes in relation to heme utilization.
Construction of the mutants. Sequence information was obtained from the C. neoformans var. grubii serotype A genome database (http://www.broad.mit.edu/annotation/ genome/cryptococcus_neoformans). The mutants were constructed as follows. A UPC2 disruption cassette was constructed by overlapping PCR using the primers UPC2-KO1, UPC2-KO2, UPC2-KO3, UPC2-KO4, UPC2-KO5 and UPC2-KO6 (Table 1) , with genomic DNA and the plasmid pCH233 as templates [25, 26] . The amplified disruption cassette was biolistically transformed into the wildtype strain as previously described [27] . The 2,524 bp genomic region containing the entire coding sequence of UPC2 was replaced with the nourseothricin acetyltransferase gene (NAT) using the 5' and 3' flanking sequences of UPC2. Positive transformants were identified by PCR. Four independent mutants were selected and used throughout the study.
Phenotypic analysis. To analyze antifungal susceptibility, 10-fold serial dilutions of cells were spotted onto YPD plates containing fluconazole or amphotericin B. Plates were incubated at 30 o C for two days. To investigate phenotypes related to iron utilization, strains were first grown in low-iron medium at 30 o C overnight in order to deplete intracellular iron. Cells were serially diluted 10-fold and spotted onto low-or high-iron media.
Results and Discussion
Identification of the Upc2 homolog in C. neoformans and construction of the mutants. The sequence of S. cerevisiae Upc2 was used to search for its ortholog in C. neoformans. The search resulted in the identification of a gene, CNAG_03115.2 on chromosome 8, which contains a fungal Zn(2)-Cys(6) binuclear cluster domain. To determine gene function, mutants lacking UPC2 were constructed by homologous recombination (see Materials and Methods). Positive transformants were selected and confirmed by PCR (data not shown). Four independent mutants were used throughout the experiments.
Roles of Upc2 in antifungal susceptibility. In S. cerevisiae, Upc2 influences ergosterol synthesis and susceptibility to antifungal drugs. Moreover, C. albicans mutants lacking CaUPC2 displayed significantly increased sensitivity to the azole antifungal drugs ketoconazole and fluconazole, and overexpression of CaUpc2 increased resistance to these drugs [22] . In this study, we investigated the susceptibility of the C. neoformans upc2 mutants to antifungal drugs. Growth of the mutants was analyzed on media containing fluconazole or polyene antifungal drug amphotericin B. The mutants grew equally well and showed no significant difference compared to the wild type (Fig. 1) . This suggests that Upc2 played no role in relation to susceptibility to fluconazole or amphotericin B. Furthermore, unlike S. cerevisiae and C. albicans, C. neoformans may possess different regulatory mechanisms to regulate the genes involved in ergosterol synthesis. Roles of Upc2 in iron utilization. Iron utilization and metabolism are known to be related to ergosterol synthesis in S. cerevisiae and C. albicans. A number of studies have suggested that ergosterol synthesis relies on iron metabolism in S. cerevisiae [28, 29] . Examples include the influence of cytosolic iron levels on Erg25, which is a C-4 methyl sterol oxidase (Erg25) in ergosterol synthesis [30] . Similarly, susceptibility of C. albicans to antifungal drugs has also been shown to be influenced by the availability of iron. Moreover, C. albicans lacking iron permease Ftr1 displayed increased sensitivity to fluconazole [31] . Recently, we also found that C. neoformans mutants lacking the reductive iron uptake pathway show increased susceptibility to antifungal drugs [23, 32] . In this study, we tested whether the C. neoformans upc2 mutants would show a deficiency in iron uptake. Unlike S. cerevisiae and C. albicans, the C. neoformans upc2 mutants displayed no change in growth in both low-and high-iron media (Fig.  2) . These results suggested that the Upc2 ortholog in C. neoformans plays distinct roles compared to S. cerevisiae and C. albicans. 
